Supplementary Fig. 2 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Unknown|2023Cited by 0
Supplementary Fig. 8 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Unknown|2023Cited by 0
Supplementary Fig. 3 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Unknown|2023Cited by 0
Supplementary Fig. 4 from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Unknown|2023Cited by 0
Supplementary Table S3. from Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Unknown|2023Cited by 0